 |
 |
 |
 |
 |
 |
 |
 |
肺癌入腦令人如中風 第二代ALK肺癌標靶藥助更好控制病情
新式藥物如針對ALK肺癌的第二代標靶藥物，有效控病而且入腦性強，在第一代ALK肺癌標靶藥無效後轉用第二代ALK肺癌標靶藥物可帶來長達16個月的無惡化存活期。
Webinar: European Metastatic Pancreatic Cancer (mPaCa) Treatment Landscape and the Relevance to Clinical Practice in Hong Kong
Webinar: European Metastatic Pancreatic Cancer (mPaCa) Treatment Landscape and the Relevance to Clinical Practice in Hong Kong
